Literature DB >> 2013626

Automated microparticle enzyme immunoassays for IgG and IgM antibodies to Toxoplasma gondii.

J W Safford1, G G Abbott, M C Craine, R G MacDonald.   

Abstract

Fully automated microparticle enzyme immunoassays (MEIA) for the IMx immunoassay analyser were developed to detect IgG and IgM antibodies to Toxoplasma gondii. The IgG MEIA results are expressed in International Units (IU) of IgG antibody interpolated from a six point calibration curve covering the range from 0 to 300 IU/ml. Reproducible results were obtained from a calibration curve stored in the instrument for at least one month. The qualitative IgM MEIA expresses results as an index using a single calibrator included in each run. The Toxo IgG MEIA and Toxo IgM MEIA were in 98% and 97% agreement, respectively, with the reference assays used. Twenty four sera can be completely processed in about 35 minutes.

Mesh:

Substances:

Year:  1991        PMID: 2013626      PMCID: PMC496947          DOI: 10.1136/jcp.44.3.238

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Toxoplasmosis: the time has come.

Authors:  R McCabe; J S Remington
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

2.  Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.

Authors:  F Daffos; F Forestier; M Capella-Pavlovsky; P Thulliez; C Aufrant; D Valenti; W L Cox
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

3.  Development of automated immunoassays for immune status screening and serodiagnosis of rubella virus infection.

Authors:  G G Abbott; J W Safford; R G MacDonald; M C Craine; R R Applegren
Journal:  J Virol Methods       Date:  1990-02       Impact factor: 2.014

4.  Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.

Authors:  J A Cohn; A McMeeking; W Cohen; J Jacobs; R S Holzman
Journal:  Am J Med       Date:  1989-05       Impact factor: 4.965

5.  Prenatal diagnosis of congenital toxoplasmosis.

Authors:  G Desmonts; F Daffos; F Forestier; M Capella-Pavlovsky; P Thulliez; M Chartier
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

6.  Modification of host cell phagosomes by Toxoplasma gondii involves redistribution of surface proteins and secretion of a 32 kDa protein.

Authors:  L D Sibley; J L Krahenbuhl
Journal:  Eur J Cell Biol       Date:  1988-10       Impact factor: 4.492

7.  Toxoplasma gondii: redistribution of monoclonal antibodies on tachyzoites during host cell invasion.

Authors:  J F Dubremetz; C Rodriguez; E Ferreira
Journal:  Exp Parasitol       Date:  1985-02       Impact factor: 2.011

8.  Antigen(s) responsible for immunoglobulin G responses specific for the acute stage of Toxoplasma infection in humans.

Authors:  Y Suzuki; P Thulliez; G Desmonts; J S Remington
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

9.  Toxoplasmosis in heart and heart and lung transplant recipients.

Authors:  T G Wreghitt; M Hakim; J J Gray; A H Balfour; P G Stovin; S Stewart; J Scott; T A English; J Wallwork
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

10.  Use of monoclonal antibodies to human immunoglobulin M in "capture" assays for measles and rubella immunoglobulin M.

Authors:  B Forghani; C K Myoraku; N J Schmidt
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

View more
  2 in total

1.  False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.

Authors:  O Liesenfeld; C Press; J G Montoya; R Gill; J L Isaac-Renton; K Hedman; J S Remington
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

2.  Recombinant mouse-human chimeric antibodies as calibrators in immunoassays that measure antibodies to Toxoplasma gondii.

Authors:  J Hackett; J Hoff-Velk; A Golden; J Brashear; J Robinson; M Rapp; M Klass; D H Ostrow; W Mandecki
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.